Against the Clock: the Bundibugyo Ebola Outbreak
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
Research into new Ebola vaccines and therapeutics, ranging from prophylaxis to post-exposure prophylaxis treatment candidates, are being fast-tracked, using similar mechanisms to fast-tracked COVID-19 trials. Even so, there are legitimate concerns that the Bundibugyo strain of the Ebola virus is moving faster than the response of technology developers, regulators, governments, and international organizations.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Vaccine reports
New
New
New